Angela S. García-Vega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Angela S. García-Vega has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Adriana María García Muñoz
1 shared publicationAlba Mery Gómez Castañeda
1 shared publicationAna Maria Montoya
1 shared publicationAna Yadira Santana
1 shared publicationAndrés F. Arias
1 shared publicationAnthony P. Underwood
Centre for Genomic Pathogen Surveillance, Pandemics Science Institute, University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- Open Access
- 21 July 2025
- Published by Springer Nature in npj Antimicrobials and Resistance
- Vol. 3 (1) , 1-11
Epidemiological Genomics of Klebsiella pneumoniae isolates from hospitals across Colombia
Klebsiella pneumoniae is one of the most important nosocomial pathogens worldwide. In Colombia, K. pneumoniae has been identified as the second most frequent microbial etiologic agent of healthcare-associated infections. We conducted a prospective local study of 335 K. pneumoniae isolates in 26 nationwide hospitals from 2020 to 2021. We found that the spread of carbapenem resistance was mediated by successful clones belonging to sequence types (ST) such as ST11, ST1082, and ST307, related to intra-hospital infections. We observed that blaKPC remains the primary resistance mechanism to carbapenems and that, unlike other countries, ST11 strains commonly carry blaKPC-3. We identified the recent introduction and circulation of new sequence types with different resistance mechanisms and hypervirulence. Besides, we detected possible transmission events closely linked to carbapenemase-carrying strains, mainly in intensive care units. This study helps us understand how K. pneumoniae disseminates in Colombian hospitals and where to direct effective intervention measures.
- 21 July 2025
- Published by Springer Nature in npj Antimicrobials and Resistance
- Vol. 3 (1) , 1-11
Open AccessEpidemiological Genomics of Klebsiella pneumoniae isolates from hospitals across Colombia
Klebsiella pneumoniae is one of the most important nosocomial pathogens worldwide. In Colombia, K. pneumoniae has been identified as the second most frequent microbial etiologic agent of healthcare-associated infections. We conducted a prospective local study of 335 K. pneumoniae isolates in 26 nationwide hospitals from 2020 to 2021. We found that the spread of carbapenem resistance was mediated by successful clones belonging to sequence types (ST) such as ST11, ST1082, and ST307, related to intra-hospital infections. We observed that blaKPC remains the primary resistance mechanism to carbapenems and that, unlike other countries, ST11 strains commonly carry blaKPC-3. We identified the recent introduction and circulation of new sequence types with different resistance mechanisms and hypervirulence. Besides, we detected possible transmission events closely linked to carbapenemase-carrying strains, mainly in intensive care units. This study helps us understand how K. pneumoniae disseminates in Colombian hospitals and where to direct effective intervention measures.